CS
IDYA icon

Candriam SCA’s IDEAYA Biosciences IDYA Stock Holding History

Candriam SCA’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.7M Sell
1,092,301
-15,407
-1% -$472K 0.18% 117
2026
Q1 		$36.9M Buy
1,107,708
+76,354
+7% +$2.56M 0.19% 119
2025
Q4 		$35.7M Buy
1,031,354
+18,387
+2% +$586K 0.18% 127
2025
Q3 		$27.6M Buy
1,012,967
+98,567
+11% +$2.38M 0.14% 139
2025
Q2 		$19.2M Sell
914,400
-23,777
-3% -$456K 0.11% 170
2025
Q1 		$15.4M Sell
938,177
-133,648
-12% -$2.85M 0.1% 192
2024
Q4 		$27.5M Buy
1,071,825
+131,385
+14% +$3.72M 0.16% 129
2024
Q3 		$29.8M Buy
940,440
+311,421
+50% +$11.8M 0.17% 127
2024
Q2 		$22.1M Sell
629,019
-1,000
-0.2% -$39.6K 0.13% 152
2024
Q1 		$27.6M Buy
630,019
+235,000
+59% +$10.1M 0.18% 129
2023
Q4 		$14.1M Sell
395,019
-35,000
-8% -$1.04M 0.1% 214
2023
Q3 		$11.6M Buy
430,019
+19,999
+5% +$507K 0.08% 213
2023
Q2 		$9.64M Buy
410,020
+129,703
+46% +$2.67M 0.07% 252
2023
Q1 		$3.54M Hold
280,317
– – 0.02% 447
2022
Q4 		$5.09M Buy
280,317
+25,000
+10% +$421K 0.03% 375
2022
Q3 		$3.81M Buy
+255,317
New +$3.32M 0.03% 443

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Candriam SCA's IDYA Position: Q2 2026 in Review

Candriam SCA reduced its IDEAYA Biosciences (IDYA) stake by 1.4% in Q2 2026, selling an estimated $472K and leaving 1,092,301 shares worth $40.7M. The position accounts for 0.18% of the portfolio, ranked #117.

Candriam SCA first reported a position in IDYA in Q3 2022 and has held it in 16 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Candriam SCA held 1,092,301 shares of IDEAYA Biosciences worth $40.7M as of Q2 2026.
  • Candriam SCA sold 15,407 IDEAYA Biosciences shares in Q2 2026, an estimated $472K.
  • IDEAYA Biosciences made up 0.18% of Candriam SCA's portfolio in Q2 2026, its #117 holding.
  • Candriam SCA first reported a position in IDEAYA Biosciences in Q3 2022 and has held it in 16 quarters since.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.